Northern Trust
DFTX

Northern Trust’s Definium Therapeutics DFTX Stock Holding History

Northern Trust’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55M Buy
1,169,238
+370,251
+46% +$9.15M 0.01% 1145
2026
Q1 		$15.1M Buy
798,987
+64,327
+9% +$1.09M ﹤0.01% 1840
2025
Q4 		$9.84M Buy
734,660
+106,122
+17% +$1.31M ﹤0.01% 2098
2025
Q3 		$7.41M Buy
628,538
+29,296
+5% +$273K ﹤0.01% 2277
2025
Q2 		$3.89M Sell
599,242
-43,541
-7% -$286K ﹤0.01% 2605
2025
Q1 		$3.76M Sell
642,783
-42,053
-6% -$301K ﹤0.01% 2571
2024
Q4 		$4.77M Buy
684,836
+76,559
+13% +$527K ﹤0.01% 2534
2024
Q3 		$3.46M Buy
608,277
+424,363
+231% +$2.95M ﹤0.01% 2692
2024
Q2 		$1.33M Buy
183,914
+118,365
+181% +$1.04M ﹤0.01% 3119
2024
Q1 		$616K Buy
65,549
+3,486
+6% +$19.9K ﹤0.01% 3489
2023
Q4 		$227K Sell
62,063
-193
-0.3% -$581 ﹤0.01% 3857
2023
Q3 		$195K Buy
62,256
+224
+0.4% +$921 ﹤0.01% 3822
2023
Q2 		$221K Buy
62,032
+3,641
+6% +$12.6K ﹤0.01% 3787
2023
Q1 		$185K Buy
58,391
+2,703
+5% +$8.99K ﹤0.01% 3891
2022
Q4 		$123K Buy
+55,688
New +$155K ﹤0.01% 4026
2022
Q2 		– Sell
-151,468
Closed -$2.52M – 4790
2022
Q1 		$2.52M Sell
151,468
-17,812
-11% -$309K ﹤0.01% 2979
2021
Q4 		$3.5M Sell
169,280
-3,341
-2% -$107K ﹤0.01% 2915
2021
Q3 		$6.03M Buy
172,621
+158,030
+1,083% +$6.83M ﹤0.01% 2614
2021
Q2 		$755K Buy
+14,591
New +$766K ﹤0.01% 3599

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Northern Trust's DFTX Position: Q2 2026 in Review

Northern Trust increased its Definium Therapeutics (DFTX) stake by 46% in Q2 2026, buying an estimated $9.15M and bringing the position to 1,169,238 shares worth $55M. The position accounts for 0.01% of the portfolio, ranked #1145.

Northern Trust first reported a position in DFTX in Q2 2021 and has held it in 19 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Northern Trust held 1,169,238 shares of Definium Therapeutics worth $55M as of Q2 2026.
  • Northern Trust bought 370,251 Definium Therapeutics shares in Q2 2026, an estimated $9.15M.
  • Definium Therapeutics made up 0.01% of Northern Trust's portfolio in Q2 2026, its #1145 holding.
  • Northern Trust first reported a position in Definium Therapeutics in Q2 2021 and has held it in 19 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.